Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortBoosted protease inhibitor for HIV, mostly used as a second-line option.Core of the WHO-preferred HIV treatment.
Body systemAntiviralsAntivirals
Drug classViral protease inhibitorsIntegrase inhibitors
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesHIV infection (with other drugs)HIV-1 treatment (with other antiretrovirals)
How it worksStops HIV from maturing into infectious viruses.Stops HIV inserting its genes into your cells' DNA.
Starts workingWeeks—
Half-life5–6 hoursAbout 14 hours
Typical adult dose400/100 mg twice a day, or 800/200 mg once a day in some patients.50 mg once a day (twice a day with rifampicin or certain resistance).
FormsTablet, Oral solutionTablet, Dispersible tablet, Combination tablets (TLD, Triumeq, Dovato)
Common side effectsDiarrhoea, Nausea, Raised cholesterol and triglycerides, TirednessHeadache, Insomnia, Weight gain, Nausea
Serious side effectsPancreatitis, Liver injury, QT and PR prolongation, Insulin resistanceHypersensitivity reaction (rare), Liver injury in hepatitis co-infection, Depression (rare)
Don't take ifTaking simvastatin, lovastatin, rifampicin, St John's wort; Severe liver disease—
AlcoholBest to limit. Alcohol increases pancreatitis and liver risk.—
PregnancyGenerally considered safeWidely used in pregnancy within HIV regimens.Generally considered safeAn early signal of neural tube defects shrank with more data; WHO recommends it for all, including in pregnancy.
BreastfeedingUsually avoidedNot recommended where safe formula is available.—
In use since—2013
Brand namesUnited States: KaletraUnited Kingdom: KaletraIndia: Lopimune, Lopinavir-ritonavir (generic)United States: TivicayUnited Kingdom: TivicayAustralia: Tivicay
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H—
ATC codeJ05AR10J05AJ03

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker